215 related articles for article (PubMed ID: 30448564)
41. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
42. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
[TBL] [Abstract][Full Text] [Related]
43. Prion protein protects mice from lethal infection with influenza A viruses.
Chida J; Hara H; Yano M; Uchiyama K; Das NR; Takahashi E; Miyata H; Tomioka Y; Ito T; Kido H; Sakaguchi S
PLoS Pathog; 2018 May; 14(5):e1007049. PubMed ID: 29723291
[TBL] [Abstract][Full Text] [Related]
44. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
Filesi I; Cardinale A; Mattei S; Biocca S
J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
[TBL] [Abstract][Full Text] [Related]
45. Anti-prion antibodies for prophylaxis following prion exposure in mice.
Sigurdsson EM; Sy MS; Li R; Scholtzova H; Kascsak RJ; Kascsak R; Carp R; Meeker HC; Frangione B; Wisniewski T
Neurosci Lett; 2003 Jan; 336(3):185-7. PubMed ID: 12505623
[TBL] [Abstract][Full Text] [Related]
46. Mucosal vaccination delays or prevents prion infection via an oral route.
Goñi F; Knudsen E; Schreiber F; Scholtzova H; Pankiewicz J; Carp R; Meeker HC; Rubenstein R; Brown DR; Sy MS; Chabalgoity JA; Sigurdsson EM; Wisniewski T
Neuroscience; 2005; 133(2):413-21. PubMed ID: 15878645
[TBL] [Abstract][Full Text] [Related]
47. The sheddase ADAM10 is a potent modulator of prion disease.
Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
Elife; 2015 Feb; 4():. PubMed ID: 25654651
[TBL] [Abstract][Full Text] [Related]
48. The function of the cellular prion protein in health and disease.
Watts JC; Bourkas MEC; Arshad H
Acta Neuropathol; 2018 Feb; 135(2):159-178. PubMed ID: 29151170
[TBL] [Abstract][Full Text] [Related]
49. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
50. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
51. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
52. Developmental expression of the cellular prion protein (PrP(C) ) in bovine embryos.
Peralta OA; Huckle WR; Eyestone WH
Mol Reprod Dev; 2012 Jul; 79(7):488-98. PubMed ID: 22674901
[TBL] [Abstract][Full Text] [Related]
53. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.
Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G
Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583
[TBL] [Abstract][Full Text] [Related]
54. Cellular prion protein signaling in serotonergic neuronal cells.
Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
[TBL] [Abstract][Full Text] [Related]
55. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
56. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
57. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
Benvegnù S; Poggiolini I; Legname G
J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
[TBL] [Abstract][Full Text] [Related]
58. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.
Choi CJ; Anantharam V; Saetveit NJ; Houk RS; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2007 Aug; 98(2):495-509. PubMed ID: 17483122
[TBL] [Abstract][Full Text] [Related]
59. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
60. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.
Puig B; Altmeppen HC; Linsenmeier L; Chakroun K; Wegwitz F; Piontek UK; Tatzelt J; Bate C; Magnus T; Glatzel M
PLoS Pathog; 2019 Jan; 15(1):e1007520. PubMed ID: 30608982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
